Weekly updateCompaniesRecruiting servicePost a job
Rain Therapeutics

Rain Therapeutics

    Company info:

  • 1-50
  • 2017
  • Newark, CA
  • 10-100M



Claim company profile

About company:

Rain Therapeutics is developing targeted therapies for cancer patients. Precision oncology prioritizes pairing drugs with cancer patients and underlies Rain’s development philosophy. Rain is designing drugs to target aberrant genetic or cell signaling networks in cancer and is employing diagnostic assays to identify biomarkers predictive of efficacy. This involves tumor genetic testing with the aim of maximizing patient benefit. Rain’s lead drug candidate, milademetan, is currently in clinical development for patients with liposarcoma. Milademetan is an oral small molecule inhibitor of MDM2, which is commonly over-amplified in cancer. Rain also has a research program in preclinical development targeting the DNA damage response pathway and RAD52.


Rain Therapeutics
Scientist, In Vivo Pharmacology
Sunnyvale, CA|10 days ago
Rain Therapeutics
Facilities Manager
Newark, CA|35 days ago
Rain Therapeutics
Medical Science Liaison
Newark, CA|50 days ago
Rain Therapeutics
Director / Executive Director, Medical and Scientific Affair...
Newark, CA|55 days ago
Rain Therapeutics
Sr. Pharmacovigilance Scientist (PV Manager)
Newark, CA|59 days ago
Rain Therapeutics
Associate Director, Contracts - Biotech (Non-Attorney/Parale...
Newark, CA|76 days ago
Rain Therapeutics
Sr. Director/Director Chemical Development
Newark, CA|100+ days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com